Bloomberg News

Bayer May Invest to Make Kogenate at Wuppertal Plant, FTD Says

July 29, 2012

Bayer AG (BAYN) may invest in its Wuppertal plant to produce the drug Kogenate Financial Times Deutschland reported, citing unidentified people within the company.

Bayer is considering remodeling a plant formerly used to produce the drug Trasylol, and plans to spend about 80 million euros ($99 million), according to the report.

To contact the reporter on this story: Jana Randow in Frankfurt at

To contact the editor responsible for this story: Craig Stirling at

The Aging of Abercrombie & Fitch
blog comments powered by Disqus